Additional file 1 of Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study
Additional file 1. Blood loss volume in salvage surgery according to the types of prior drug therapy. ICI: Immune checkpoint inhibitor; TKI: Tyrosine kinase inhibitor.
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , |
---|---|
Format: | Video |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Suzuki, Shigeki Asakura, Keisuke Okui, Masayuki Izawa, Naoko Sawafuji, Makoto Sakamaki, Hiroyuki Shigenobu, Takao Tajima, Atsushi Oka, Naoyuki Masai, Kyohei Kaseda, Kaoru Hishida, Tomoyuki Yasuda, Hiroyuki Fukunaga, Koichi Asamura, Hisao |
description | Additional file 1. Blood loss volume in salvage surgery according to the types of prior drug therapy. ICI: Immune checkpoint inhibitor; TKI: Tyrosine kinase inhibitor. |
doi_str_mv | 10.6084/m9.figshare.24151167 |
format | Video |
fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_24151167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_24151167</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_241511673</originalsourceid><addsrcrecordid>eNqdkDFOxDAQRdNQIOAGFHOBhBiyC0uHEIiSgj4aOeNkJMeOxuOgHI-b4RW7F6CZad7_evpVdWvaZt8-dXfzoXE8pgmFmvvO7IzZP15WPy_DwMoxoAfHnsBAdPApcQwxKVtwaDVKAnSOrHIYIWVZeS08B1hQmYIm-GadIMRQpxm9B0vl-Fxoi8GSgAqh0vDHJfQrjnRsGkm20q0FGSSPoBMJLtszIMzZK9cciobmk6KQSkzL0WQtec3Ddl1dOPSJbk7_qure375eP-oBFS0r9YvwjLL1pu2PS_TzoT8v0Z-XePhn7BeMFngS</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>video</recordtype></control><display><type>video</type><title>Additional file 1 of Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study</title><source>DataCite</source><creator>Suzuki, Shigeki ; Asakura, Keisuke ; Okui, Masayuki ; Izawa, Naoko ; Sawafuji, Makoto ; Sakamaki, Hiroyuki ; Shigenobu, Takao ; Tajima, Atsushi ; Oka, Naoyuki ; Masai, Kyohei ; Kaseda, Kaoru ; Hishida, Tomoyuki ; Yasuda, Hiroyuki ; Fukunaga, Koichi ; Asamura, Hisao</creator><creatorcontrib>Suzuki, Shigeki ; Asakura, Keisuke ; Okui, Masayuki ; Izawa, Naoko ; Sawafuji, Makoto ; Sakamaki, Hiroyuki ; Shigenobu, Takao ; Tajima, Atsushi ; Oka, Naoyuki ; Masai, Kyohei ; Kaseda, Kaoru ; Hishida, Tomoyuki ; Yasuda, Hiroyuki ; Fukunaga, Koichi ; Asamura, Hisao</creatorcontrib><description>Additional file 1. Blood loss volume in salvage surgery according to the types of prior drug therapy. ICI: Immune checkpoint inhibitor; TKI: Tyrosine kinase inhibitor.</description><identifier>DOI: 10.6084/m9.figshare.24151167</identifier><language>eng</language><publisher>figshare</publisher><subject>Biotechnology ; Cancer ; Hematology ; Mathematical Sciences not elsewhere classified ; Medicine ; Pharmacology</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.24151167$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Suzuki, Shigeki</creatorcontrib><creatorcontrib>Asakura, Keisuke</creatorcontrib><creatorcontrib>Okui, Masayuki</creatorcontrib><creatorcontrib>Izawa, Naoko</creatorcontrib><creatorcontrib>Sawafuji, Makoto</creatorcontrib><creatorcontrib>Sakamaki, Hiroyuki</creatorcontrib><creatorcontrib>Shigenobu, Takao</creatorcontrib><creatorcontrib>Tajima, Atsushi</creatorcontrib><creatorcontrib>Oka, Naoyuki</creatorcontrib><creatorcontrib>Masai, Kyohei</creatorcontrib><creatorcontrib>Kaseda, Kaoru</creatorcontrib><creatorcontrib>Hishida, Tomoyuki</creatorcontrib><creatorcontrib>Yasuda, Hiroyuki</creatorcontrib><creatorcontrib>Fukunaga, Koichi</creatorcontrib><creatorcontrib>Asamura, Hisao</creatorcontrib><title>Additional file 1 of Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study</title><description>Additional file 1. Blood loss volume in salvage surgery according to the types of prior drug therapy. ICI: Immune checkpoint inhibitor; TKI: Tyrosine kinase inhibitor.</description><subject>Biotechnology</subject><subject>Cancer</subject><subject>Hematology</subject><subject>Mathematical Sciences not elsewhere classified</subject><subject>Medicine</subject><subject>Pharmacology</subject><fulltext>true</fulltext><rsrctype>video</rsrctype><creationdate>2023</creationdate><recordtype>video</recordtype><sourceid>PQ8</sourceid><recordid>eNqdkDFOxDAQRdNQIOAGFHOBhBiyC0uHEIiSgj4aOeNkJMeOxuOgHI-b4RW7F6CZad7_evpVdWvaZt8-dXfzoXE8pgmFmvvO7IzZP15WPy_DwMoxoAfHnsBAdPApcQwxKVtwaDVKAnSOrHIYIWVZeS08B1hQmYIm-GadIMRQpxm9B0vl-Fxoi8GSgAqh0vDHJfQrjnRsGkm20q0FGSSPoBMJLtszIMzZK9cciobmk6KQSkzL0WQtec3Ddl1dOPSJbk7_qure375eP-oBFS0r9YvwjLL1pu2PS_TzoT8v0Z-XePhn7BeMFngS</recordid><startdate>20230916</startdate><enddate>20230916</enddate><creator>Suzuki, Shigeki</creator><creator>Asakura, Keisuke</creator><creator>Okui, Masayuki</creator><creator>Izawa, Naoko</creator><creator>Sawafuji, Makoto</creator><creator>Sakamaki, Hiroyuki</creator><creator>Shigenobu, Takao</creator><creator>Tajima, Atsushi</creator><creator>Oka, Naoyuki</creator><creator>Masai, Kyohei</creator><creator>Kaseda, Kaoru</creator><creator>Hishida, Tomoyuki</creator><creator>Yasuda, Hiroyuki</creator><creator>Fukunaga, Koichi</creator><creator>Asamura, Hisao</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20230916</creationdate><title>Additional file 1 of Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study</title><author>Suzuki, Shigeki ; Asakura, Keisuke ; Okui, Masayuki ; Izawa, Naoko ; Sawafuji, Makoto ; Sakamaki, Hiroyuki ; Shigenobu, Takao ; Tajima, Atsushi ; Oka, Naoyuki ; Masai, Kyohei ; Kaseda, Kaoru ; Hishida, Tomoyuki ; Yasuda, Hiroyuki ; Fukunaga, Koichi ; Asamura, Hisao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_241511673</frbrgroupid><rsrctype>videos</rsrctype><prefilter>videos</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biotechnology</topic><topic>Cancer</topic><topic>Hematology</topic><topic>Mathematical Sciences not elsewhere classified</topic><topic>Medicine</topic><topic>Pharmacology</topic><toplevel>online_resources</toplevel><creatorcontrib>Suzuki, Shigeki</creatorcontrib><creatorcontrib>Asakura, Keisuke</creatorcontrib><creatorcontrib>Okui, Masayuki</creatorcontrib><creatorcontrib>Izawa, Naoko</creatorcontrib><creatorcontrib>Sawafuji, Makoto</creatorcontrib><creatorcontrib>Sakamaki, Hiroyuki</creatorcontrib><creatorcontrib>Shigenobu, Takao</creatorcontrib><creatorcontrib>Tajima, Atsushi</creatorcontrib><creatorcontrib>Oka, Naoyuki</creatorcontrib><creatorcontrib>Masai, Kyohei</creatorcontrib><creatorcontrib>Kaseda, Kaoru</creatorcontrib><creatorcontrib>Hishida, Tomoyuki</creatorcontrib><creatorcontrib>Yasuda, Hiroyuki</creatorcontrib><creatorcontrib>Fukunaga, Koichi</creatorcontrib><creatorcontrib>Asamura, Hisao</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Suzuki, Shigeki</au><au>Asakura, Keisuke</au><au>Okui, Masayuki</au><au>Izawa, Naoko</au><au>Sawafuji, Makoto</au><au>Sakamaki, Hiroyuki</au><au>Shigenobu, Takao</au><au>Tajima, Atsushi</au><au>Oka, Naoyuki</au><au>Masai, Kyohei</au><au>Kaseda, Kaoru</au><au>Hishida, Tomoyuki</au><au>Yasuda, Hiroyuki</au><au>Fukunaga, Koichi</au><au>Asamura, Hisao</au><genre>unknown</genre><ristype>VIDEO</ristype><title>Additional file 1 of Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study</title><date>2023-09-16</date><risdate>2023</risdate><abstract>Additional file 1. Blood loss volume in salvage surgery according to the types of prior drug therapy. ICI: Immune checkpoint inhibitor; TKI: Tyrosine kinase inhibitor.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.24151167</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | DOI: 10.6084/m9.figshare.24151167 |
ispartof | |
issn | |
language | eng |
recordid | cdi_datacite_primary_10_6084_m9_figshare_24151167 |
source | DataCite |
subjects | Biotechnology Cancer Hematology Mathematical Sciences not elsewhere classified Medicine Pharmacology |
title | Additional file 1 of Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A29%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:&rft.genre=unknown&rft.au=Suzuki,%20Shigeki&rft.date=2023-09-16&rft_id=info:doi/10.6084/m9.figshare.24151167&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_24151167%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |